Jonathan M. Sedgh

Top rated Products Liability attorney in New York, New York

Morgan & Morgan
Jonathan M. Sedgh
Morgan & Morgan

Practice Areas: Products Liability, Personal Injury; view more

Licensed in New York since: 2008

Education: Hofstra University School of Law

Selected to Rising Stars: 2015 - 2021
Free Consultation

Morgan & Morgan

350 5th Ave
Suite 6705
New York, NY 10118 Visit website


Jonathan M. Sedgh is a Mass Tort Product Liability Partner at Morgan & Morgan's Manhattan ofdice in the Empire State Building. Over the course of more than 15 years practicing law, he has played an instrumental role in various lawsuits against the makers of dangerous and defective pharmaceuticals and medical devices. He also helps survivors of sex trafficking and childhood sexual abuse pursue justice against their perpetrators, institutions and the hotel industry who turned a blind eye to their victimization.

Mr. Sedgh has been a key figure in more than a dozen multi-district litigations and state-court coordinated actions where he managed and litigated thousands of cases from inception to settlement or trial.

Notably, in 2014, Mr. Sedgh helped recover a $9 billion verdict in a three-month trial for his client who developed bladder cancer after taking Actos, an anti-diabetic medication. The drug, manufactured by Takeda and marketed in the U.S. by Eli Lilly, had been linked to an increased risk for the condition. The suit alleged that the two companies continued to manufacture and market the drug despite knowing of its dangers, and that they failed to inform patients and the medical community. The civil verdict, delivered by a jury of eight, is still one of the largest jury awards in history.

In November 2021, Mr. Sedgh was part of the trial team where a federal jury held the 3M company liable for an Army Sergeant's hearing loss from faulty combat earplugs. A Tallahassee jury awarded the U.S. Army Sergeant $816,395 in compensatory damages and $12.245 million in punitive damages, making it the largest win at that time for the roughly 250,000 plaintiffs in the litigation.

In September 2022, Mr. Sedgh was one of 12 attorneys appointed to the Plaintiffs’ Leadership Committee in the Abbott Infant Formula Recall Multi-District Litigation. This committee was selected to represent the national interest of thousands of children across the country who were injured following their ingestion of contaminated baby formula stemming from a production facility in Michigan.  

In light of his achievements, Mr. Sedgh was named a Top-Rated Products Liability Attorney in New York City and a Rising Star by Super Lawyers magazine. The National Trial Lawyers, an association promoting excellence in the legal profession, designated him as a Top 40 Under 40 Trial Attorney. Mr. Sedgh has been awarded each of these prestigious honors consecutively from 2015 to 2021. The National Trial Lawyers selected Mr. Sedgh as one of their Top 100 Lawyers in 2022 given his accomplishments and fight for advocacy both inside and outside the courtroom. 

Over the years, Mr. Sedgh has been a speaker and panelist at mass-tort product liability seminars around the United States. He is a member of the bar associations of New York State and New York City. In 2011, the New York City bar association hand-selected him as one of 25 attorneys to serve on its product liability committee, an exclusive group that includes the in-house counsel of major pharmaceutical and medical device companies

Practice areas

Personal Injury - Products: Plaintiff, Personal Injury - General: Plaintiff

Focus areas

Medical Devices, Motor Vehicle Accidents, Personal Injury - Plaintiff, Pharmaceutical, Slip and Fall

  • 90% Personal Injury - Products: Plaintiff
  • 10% Personal Injury - General: Plaintiff

First Admitted: 2008, New York

Professional Webpage:

Other Outstanding Achievements:
  • The National Trial Lawyers Top 40 Under 40.
Educational Background:
  • Hofstra University School
  • Allen v. Takeda Pharmaceuticals Int'l Inc., 2014 WL 1818048 (2014) Drug manufacturers concealed risks of patients developing bladder cancer associated with taking drug to treat Type 2 Diabetes Mellitus (Actos) and failed to adequately warn prescribing physicians and their patients of such risks. Verdict: Plaintiffs, $9,001,475,000.00 $6,000,000,000.00 to plaintiffs from Takeda defendants for punitive damages $3,000,000,000.00 to plaintiffs from Eli Lilly and Company for punitive damages $75,000.00 to plaintiff Terrence Allen for past pain and suffering $75,000.00 to plaintiff Terrence Allen for past medical expenses $500,000.00 to plaintiff Terrence Allen for future pain and suffering $500,000.00 to plaintiff Terrence Allen for future medical expenses $75,0000.00 to plaintiff Susan Allen for past loss of consortium $250,000.00 to plaintiff Susan Allen for future loss of consortium The jury determined the Takeda defendants were 75 percent at fault for the plaintiffs' damages while Eli Lilly and Company was 25 percent at fault.
Bar/Professional Activity:
  • National Trial Lawyers American Association for Justice New York State Bar Association New York City Bar Association
Industry Groups:
  • Personal Injury

Office location for Jonathan M. Sedgh

350 5th Ave
Suite 6705
New York, NY 10118

Phone: 212-738-6839


7 Years Rising Stars
  • Rising Stars: 2015 - 2021

Additional sources of information about Jonathan M. Sedgh

Attorney resources for Jonathan M. Sedgh

Page Generated: 0.20123600959778 sec